Interim report January – March 2021
First quarter in brief · Net sales amounted to 14.7 million SEK (12.5), which means a sales growth of 17 percent. · Operating profit amounted to 2.5 million SEK (0.8). · Net profit for the period amounted to 2.7 million SEK (0.8). · Earnings per share amounted to 0.67 SEK (0.21). Significant events during the first quarter During the period, SyntheticMR reached the highest quarterly sales ever during the first quarter. A global license agreement has been signed with United Imaging regarding marketing and sales of SyMRI NEURO. A first order from United